Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage | Katarina Bačević et al. | ResearchPod

Transcript: Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

Alex: Welcome to another episode of ResearchPod.

Sam: Today we're looking at a protein called Cdk2 and its role in cancer cells. For years, scientists viewed it as a kind of accelerator pedal that cancer cells press to keep dividing. But this study reveals it's more of a double-edged sword: removing it doesn't just slow the cell down—it actually forces the cell into a state of permanent retirement. Scientists call that state senescence.

Alex: So the central puzzle is whether removing this accelerator does more than just stop the car—does it actually disable the engine entirely?

Sam: That's a good way to frame it. Think of the cell cycle—the process a cell goes through when it copies itself and divides—as a car journey. Cdk2 is the accelerator pedal. We used to think that without it, the car simply coasts to a stop and sits there, ready to drive again later. But the researchers found something more consequential: removing Cdk2 also causes the cell to lose a second protein called Cdk6, which acts like the fuel line. And without a fuel line, the engine can't restart at all. The cell is permanently parked.

Alex: So the two are connected. Lose the accelerator, and you automatically lose the fuel line as well?

Sam: Right. And here's the trigger for that whole chain of events. When a cell detects DNA damage—imagine a photocopier jamming mid-copy—it produces a protein called p21, which acts like a hand brake on Cdk2. The researchers found that this hand brake isn't just a temporary pause. It's a signal telling the cell to exit the cycle permanently. The p21 shuts down Cdk2, which then leads to the loss of Cdk6, and the cell never divides again.

Alex: If that's the case, why was there so much confusion about Cdk2's role for so long?

Sam: It comes down to a biological backup system. Cells are built with redundancy—if one part fails, another can often cover for it. In this case, a closely related protein called Cdk1 can step in and do Cdk2's job well enough that the cell keeps dividing. So in experiments where scientists removed Cdk2, Cdk1 quietly filled the gap, and Cdk2 appeared less important than it actually was.

Alex: The backup system was masking what Cdk2 was uniquely responsible for.

Sam: Exactly. And what it's uniquely responsible for turns out to be significant. When Cdk2 is gone, the cell struggles to handle what's called replication stress—the strain that builds up when DNA isn't being copied correctly. There's a network of proteins whose job is to detect that kind of damage and coordinate repairs. Cdk2 appears to be essential for keeping that network functional. Without it, the alarm system weakens, and the cell loses its ability to manage the damage properly.

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

Katarina Bačević, Gérald Lossaint, Thiziri Nait Achour, Virginie Georget, Daniel Fisher, Vjekoslav Dulić

Oct 12, 2017·4:03·pmc·Original Paper

Cell Cycle RegulationMolecular BiologyCancer ResearchCyclin-dependent kinase 2 (Cdk2)DNA damage response (DDR)ATR/Chk1 pathway

Listen

4 min

Briefing

Research Question

While Cdk2 is a well-known regulator of the G1/S transition, its role in the DNA damage response (DDR) has been debated, with conflicting reports suggesting it either promotes or is dispensable for G2 arrest. This study investigates whether Cdk2 differentially affects checkpoint responses in p53-proficient and p53-deficient cells, specifically focusing on how Cdk2 interacts with the p21-mediated cell cycle exit program.

Approach

Researchers used a combination of genetic knockout (Cdk2-/-) and siRNA-mediated knockdown in p53-proficient (HCT-116, U2OS) and p53-deficient (HeLa) cell lines. They subjected these cells to different stressors—hydroxyurea (HU) to induce replication stress and bleomycin/ICRF-193 to induce double-strand DNA breaks. The team monitored cell cycle progression via flow cytometry, video microscopy, and immunoblotting to track the phosphorylation status of key cell cycle regulators like Chk1, pRb, and Cdk1.

Main Findings

The study reveals that Cdk2's role is context-dependent. In response to replication stress (HU), Cdk2 is required for efficient ATR/Chk1 pathway activation. However, in response to double-strand breaks, Cdk2 is dispensable for the initial G2 arrest. Instead, the researchers found that Cdk2 inactivation is a critical step in the DDR: when Cdk2 is absent or inhibited, cells show a down-regulation of Cdk6. Because Cdk6 is a non-redundant kinase for pRb, its loss leads to the rapid appearance of markers associated with cell cycle exit. This suggests that the p21-mediated inhibition of Cdk2 serves as a regulatory switch that facilitates a timely transition from G2 arrest into permanent cell cycle exit.

Why It Matters

These findings clarify the role of Cdk2 in the DNA damage response, moving away from the view that it is a universal checkpoint promoter. By identifying Cdk2 as a key target that, when inactivated, triggers the downregulation of Cdk6 and subsequent cell cycle exit, the study provides a clearer mechanism for how cells decide between temporary arrest and permanent exit (senescence) following DNA damage.

Key Terms and Definitions

Cdk2 — A cyclin-dependent kinase that regulates the G1/S transition and, as shown here, influences the stability of the cell cycle exit program.
Cdk6 — A kinase that phosphorylates the pRb tumor suppressor, which the authors identify as a non-redundant regulator of cell cycle progression.
pRb — The retinoblastoma protein, a tumor suppressor whose phosphorylation status determines whether a cell continues to divide or exits the cell cycle.
p21 — A CDK inhibitor that, upon DNA damage, binds to and inhibits Cdk2 and Cdk1 complexes to halt the cell cycle.
Intra-S checkpoint — A regulatory mechanism that slows or stops DNA replication in response to replication stress to ensure genome integrity.

Abstract

Although cyclin-dependent kinase 2 (Cdk2) controls the G1/S transition and promotes DNA replication, it is dispensable for cell cycle progression due to redundancy with Cdk1. Yet Cdk2 also has non-redundant functions that can be revealed in certain genetic backgrounds and it was reported to promote the G2/M DNA damage response checkpoint in TP53 (p53)-deficient cancer cells. However, in p53-proficient cells subjected to DNA damage, Cdk2 is inactivated by the CDK inhibitor p21. We therefore investigated whether Cdk2 differentially affects checkpoint responses in p53-proficient and deficient cell lines. We show that, independently of p53 status, Cdk2 stimulates the ATR/Chk1 pathway and is required for an efficient DNA replication checkpoint response. In contrast, Cdk2 is not required for a sustained DNA damage response and G2 arrest. Rather, eliminating Cdk2 delays S/G2 progression after DNA damage and accelerates appearance of early markers of cell cycle exit. Notably, Cdk2 knockdown leads to down-regulation of Cdk6, which we show is a non-redundant pRb kinase whose elimination compromises cell cycle progression. Our data reinforce the notion that Cdk2 is a key p21 target in the DNA damage response whose inactivation promotes exit from the cell cycle in G2.

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage: Research Paper Podcast